Literature DB >> 18321441

Nausea and vomiting.

Pavan Chepyala1, Kevin W Olden.   

Abstract

Nausea and vomiting are symptoms resulting from a triggered emetic reflex. Many endogenous and exogenous triggering factors can activate the emetic reflex, making understanding difficult and therapy challenging. The key to managing most cases of nausea and vomiting lies in a good history and a detailed physical examination. Most episodes of acute vomiting (lasting < 48 hours) have an evident triggering factor (eg, infection, viral illness, or food poisoning) and can be managed by removing the triggering agent and via supportive therapy. Chronic and unexplained nausea and vomiting can be a challenge. The cause is often obscure and requires special investigation. Functional gastroduodenal disorders such as cyclic vomiting syndrome, functional vomiting, and chronic idiopathic nausea should be considered if investigations are unrevealing. Knowledge regarding various emetic pathways and the specific neurotransmitters involved helps to target therapy. Histamine-1 receptor antagonists and muscarinic antagonists are suitable candidates for motion sickness and labyrinthine disorders. Phenothiazines, 5-hydroxytryptamine-3 receptor antagonists, corticosteroids, and benzodiazepines have a role in postchemotherapy and postoperative nausea and vomiting. Cannabinoid and neurokinin-1 receptor antagonists are best reserved for refractory cases of nausea and vomiting. Motilin agonists and metoclopramide are useful for treating impaired gastric motility disorders.

Entities:  

Year:  2008        PMID: 18321441     DOI: 10.1007/s11938-008-0026-6

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  26 in total

1.  Comparison of the effects of a selective muscarinic receptor antagonist and hyoscine (scopolamine) on motion sickness, skin conductance and heart rate.

Authors:  J F Golding; J R Stott
Journal:  Br J Clin Pharmacol       Date:  1997-06       Impact factor: 4.335

2.  Diabetic gastroparesis.

Authors:  Eufronio G Maderazo
Journal:  N Engl J Med       Date:  2007-07-26       Impact factor: 91.245

Review 3.  Palonosetron: a second-generation 5-hydroxytryptamine receptor antagonist.

Authors:  Rudolph M Navari
Journal:  Future Oncol       Date:  2006-10       Impact factor: 3.404

Review 4.  Central neurocircuitry associated with emesis.

Authors:  P J Hornby
Journal:  Am J Med       Date:  2001-12-03       Impact factor: 4.965

Review 5.  Ondansetron. Therapeutic use as an antiemetic.

Authors:  R J Milne; R C Heel
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

Review 6.  New drugs for chemotherapy-induced nausea and vomiting: focus on palonosetron.

Authors:  Giuseppe Tonini; Bruno Vincenzi; Daniele Santini
Journal:  Expert Opin Drug Metab Toxicol       Date:  2005-06       Impact factor: 4.481

Review 7.  Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis.

Authors:  S M Grunberg
Journal:  Ann Oncol       Date:  2006-11-15       Impact factor: 32.976

8.  American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.

Authors:  Mark G Kris; Paul J Hesketh; Mark R Somerfield; Petra Feyer; Rebecca Clark-Snow; James M Koeller; Gary R Morrow; Lawrence W Chinnery; Maurice J Chesney; Richard J Gralla; Steven M Grunberg
Journal:  J Clin Oncol       Date:  2006-05-22       Impact factor: 44.544

Review 9.  Chemotherapy-induced nausea and vomiting: state of the art in 2006.

Authors:  Lee Schwartzberg
Journal:  J Support Oncol       Date:  2006-02

Review 10.  Neurokinin 1 receptor antagonists--current prospects.

Authors:  Giuseppe Alvaro; Romano Di Fabio
Journal:  Curr Opin Drug Discov Devel       Date:  2007-09
View more
  3 in total

Review 1.  Central Aspects of Nausea and Vomiting in GI Disorders.

Authors:  Prashant Singh; Braden Kuo
Journal:  Curr Treat Options Gastroenterol       Date:  2016-12

Review 2.  Nausea: a review of pathophysiology and therapeutics.

Authors:  Prashant Singh; Sonia S Yoon; Braden Kuo
Journal:  Therap Adv Gastroenterol       Date:  2016-01       Impact factor: 4.409

Review 3.  Nausea and Vomiting in 2021: A Comprehensive Update.

Authors:  Matthew Heckroth; Robert T Luckett; Chris Moser; Dipendra Parajuli; Thomas L Abell
Journal:  J Clin Gastroenterol       Date:  2021-04-01       Impact factor: 3.174

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.